Literature DB >> 1697396

Vaccine-induced escape mutant of hepatitis B virus.

W F Carman1, A R Zanetti, P Karayiannis, J Waters, G Manzillo, E Tanzi, A J Zuckerman, H C Thomas.   

Abstract

In southern Italy, 44 contacts of hepatitis B virus carriers, including infants of carrier mothers, became HBsAg positive despite passive and active immunisation according to standard protocols. In 32 of these vaccinees infection was confirmed by the presence of additional markers of viral replication. In 1 infant, serious disease occurred. The virus from this patient is an escape mutant with a different sequence from that of the isolate from the mother. A point mutation from guanosine to adenosine at nucleotide position 587 resulted in an aminoacid substitution from glycine to arginine in the highly antigenic a determinant of HBsAg. This mutation is stable: it is present in an isolate from the child 5 years later. In some of these patients, including this child, the a determinant, to which a large part of the vaccine-induced immunity is directed, has been partly lost. Binding to HBsAg of a monoclonal antibody, previously mapped to the region of the mutation, was reduced in the child relative to that of the mother.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697396     DOI: 10.1016/0140-6736(90)91874-a

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  230 in total

1.  Horizontal transmission of a hepatitis B virus surface antigen mutant.

Authors:  W N Chen; C J Oon; S Koh
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Immunopathogenesis of viral hepatitis.

Authors:  M U Mondelli
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

3.  Changes in the antigenicity of a hepatitis B virus mutant stemming from lamivudine therapy.

Authors:  W N Chen; C J Oon
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

4.  Transient expression and antigenic characterization of HBsAg of HBV nt551 A to G mutant.

Authors:  De-Xing Fang; Fa-Qing Li; Wei-Guo Tan; Hua-Biao Chen; Hui-Ying Jin; Su-Qin Li; Hou-Ji Lin; Zhen-Xian Zhou
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

5.  Immune response against HBsAg vaccine.

Authors:  Maria Cristina Honorati; Andrea Facchini
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

6.  Reappearance of hepatitis B surface antigen in immunocompromised individuals: reinfection or reactivation?

Authors:  Keisuke Hino; Ashraf A Basuni; Jacqueline Ireland; Antony Newell; Jeffrey Mphahlele; Erasmus J Smit; Siew Lin Ngui; Chong Gee Teo; William F Carman
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

Review 7.  Immune escape by hepatitis B viruses.

Authors:  U Protzer; H Schaller
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

8.  Public versus personal serotypes of a viral quasispecies.

Authors:  Lukas Hunziker; Adrian Ciurea; Mike Recher; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

9.  A novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis.

Authors:  Xu Yang; Xiao-Peng Tang; Jian-Hua Lei; Hong-Yu Luo; Yong-Hong Zhang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.

Authors:  J A Waters; M Kennedy; P Voet; P Hauser; J Petre; W Carman; H C Thomas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.